VVA
Vida Ventures Advisors Portfolio holdings
AUM
$15.9M
This Quarter Return
-25.76%
1 Year Return
+52.49%
3 Year Return
+45.65%
5 Year Return
-49.37%
10 Year Return
–
AUM
$74.4M
AUM Growth
+$74.4M
(-33%)
Cap. Flow
-$4.62M
Cap. Flow
% of AUM
-6.21%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
–
Reduced
1
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
Praxis Precision Medicines
PRAX
|
$3.5M |
| 2 |
Q32 Bio
QTTB
|
$1.12M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Dyne Therapeutics
DYN
$1.92B
| $25.7M | 34.58% |
2,220,034
| – | – |
|
|
KNTE
2
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $13.5M | 18.1% |
2,207,772
| – | – |
|
|
CNTA
3
Centessa Pharmaceuticals
CNTA
$2.25B
| $12.2M | 16.38% |
3,931,818
| – | – |
|
4
Allogene Therapeutics
ALLO
$251M
| $11.3M | 15.2% |
1,798,163
| – | – |
|
|
KRON
5
DELISTED
Kronos Bio
KRON
| $4.48M | 6.02% |
2,765,314
| – | – |
|
|
LIAN
6
DELISTED
LianBio American Depositary Shares
LIAN
| $3.74M | 5.03% |
2,282,084
| – | – |
|
|
7
Praxis Precision Medicines
PRAX
$958M
| $3.5M | 4.7% |
1,469,665
-1,469,664
| -50% | -$3.5M |
|
|
8
Q32 Bio
QTTB
$20.9M
| – | – |
-696,289
| Closed | -$1.12M |
|